Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
作者信息
Honore Patrick M, Barreto Gutierrez Leonel, Kugener Luc, Redant Sebastien, Attou Rachid, Gallerani Andrea, De Bels David
机构信息
ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital, Place Van Gehuchtenplein, 4, 1020, Brussels, Belgium.
出版信息
Crit Care. 2020 Sep 7;24(1):551. doi: 10.1186/s13054-020-03262-1.
Abstract
摘要
相似文献
1
Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
Crit Care. 2020 Sep 7;24(1):551. doi: 10.1186/s13054-020-03262-1.
2
Lung ultrasound early detection and monitoring in COVID-19 pneumonia: fact and fiction.
QJM. 2020 Aug 1;113(8):601-602. doi: 10.1093/qjmed/hcaa165.
3
TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
Crit Care. 2020 Oct 6;24(1):599. doi: 10.1186/s13054-020-03309-3.
4
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.
Br J Haematol. 2020 Nov;191(3):505-506. doi: 10.1111/bjh.17110. Epub 2020 Oct 26.
5
Comment to: Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection.
Einstein (Sao Paulo). 2020;18:eCE5931. doi: 10.31744/einstein_journal/2020ce5931. Epub 2020 Aug 5.
6
Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.
J Infect. 2020 Aug;81(2):e82-e84. doi: 10.1016/j.jinf.2020.05.021. Epub 2020 May 13.
7
Mobile X-rays are highly valuable for critically ill COVID patients.
Eur Radiol. 2020 Sep;30(9):5217-5219. doi: 10.1007/s00330-020-06918-2. Epub 2020 May 13.
8
Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19.
Expert Rev Respir Med. 2020 Nov;14(11):1071-1072. doi: 10.1080/17476348.2020.1801427. Epub 2020 Aug 11.
9
Critically ill patients with COVID-19 and candidaemia: We must keep this in mind.
J Mycol Med. 2020 Dec;30(4):101012. doi: 10.1016/j.mycmed.2020.101012. Epub 2020 Jul 4.
10
Family Member Visits to Critically Ill Patients During COVID-19: A New Pathway.
Telemed J E Health. 2020 Jul;26(7):853-854. doi: 10.1089/tmj.2020.0097. Epub 2020 Apr 21.
引用本文的文献
1
Influencing factors of hypotension during plasma exchange in patients with neuroimmunological diseases: a retrospective cohort study.
Cardiovasc Diagn Ther. 2025 Apr 30;15(2):414-422. doi: 10.21037/cdt-24-456. Epub 2025 Apr 23.
2
Liver-Support Therapies in Critical Illness-A Comparative Analysis of Procedural Characteristics and Safety.
J Clin Med. 2023 Jul 13;12(14):4669. doi: 10.3390/jcm12144669.
3
The Successful Recovery of a Critically Ill COVID-19 Patient, Following the Combination of Therapeutic Plasma Exchange and Convalescent Plasma Transfusion: A Case Report.
Medicina (Kaunas). 2022 Aug 12;58(8):1088. doi: 10.3390/medicina58081088.
4
Therapeutic plasma exchange followed by convalescent plasma transfusion in severe and critically ill COVID-19 patients: A single centre non-randomized controlled trial.
Exp Ther Med. 2022 Jan;23(1):76. doi: 10.3892/etm.2021.10999. Epub 2021 Nov 24.
5
Interim analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registry.
Nephrol Dial Transplant. 2022 Mar 25;37(4):673-680. doi: 10.1093/ndt/gfab347.
6
Plasma Exchange in Patients With Severe Coronavirus Disease 2019: A Single-Center Experience.
Crit Care Explor. 2021 Aug 20;3(8):e0517. doi: 10.1097/CCE.0000000000000517. eCollection 2021 Aug.
7
Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial.
Int J Antimicrob Agents. 2021 May;57(5):106334. doi: 10.1016/j.ijantimicag.2021.106334. Epub 2021 Apr 7.
本文引用的文献
1
Plasma exchange in critically ill COVID-19 patients.
Crit Care. 2020 Aug 4;24(1):481. doi: 10.1186/s13054-020-03171-3.
2
'Biomarking' infection during continuous renal replacement therapy: still relevant?
Crit Care. 2015 May 21;19(1):232. doi: 10.1186/s13054-015-0948-z.
3
The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis.
Crit Care. 2014 Dec 20;18(6):699. doi: 10.1186/s13054-014-0699-2.
4
Complications in patients treated with plasmapheresis in the intensive care unit.
Anaesthesiol Intensive Ther. 2013 Jan-Mar;45(1):7-13. doi: 10.5603/AIT.2013.0002.
5
Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
J Virol. 1990 Jun;64(6):3033-41. doi: 10.1128/JVI.64.6.3033-3041.1990.
Zotero 插件